We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.7B
AUM Growth
+$211M
Cap. Flow
-$755M
Cap. Flow %
-5.94%
Top 10 Hldgs %
33.79%
Holding
1,215
New
45
Increased
450
Reduced
295
Closed
31

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$108M
2
VER
VEREIT, Inc.
VER
+$105M
3
WELL icon
Welltower
WELL
+$102M
4
VTR icon
Ventas
VTR
+$88.9M
5
BXP icon
Boston Properties
BXP
+$86.8M

Top Sells

Rank Stock Value
1
EQR icon
Equity Residential
EQR
+$189M
2
GGP
GGP Inc.
GGP
+$166M
3
KRC icon
Kilroy Realty
KRC
+$93.2M
4
ESRT icon
Empire State Realty Trust
ESRT
+$92.1M
5
EPR icon
EPR Properties
EPR
+$59.2M

Sector Composition

Rank Sector Weight
1 Real Estate 73.5%
2 Industrials 3.95%
3 Technology 3.75%
4 Financials 2.75%
5 Consumer Discretionary 2.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUPH icon
1101
Aurinia Pharmaceuticals
AUPH
$1.97B
$3K ﹤0.01%
464
– –
BCRX icon
1102
BioCryst Pharmaceuticals
BCRX
$2.37B
$3K ﹤0.01%
544
– –
CBUS icon
1103
Cibus
CBUS
$130M
$3K ﹤0.01%
3
– –
ENIC icon
1104
Enel Chile
ENIC
$5.96B
$3K ﹤0.01%
+604
New +$3.49K
GERN icon
1105
Geron
GERN
$911M
$3K ﹤0.01%
880
– –
CBIO
1106
Crescent Biopharma
CBIO
$602M
$3K ﹤0.01%
2
– –
KURA icon
1107
Kura Oncology
KURA
$922M
$3K ﹤0.01%
167
– –
PRTA icon
1108
Prothena Corp
PRTA
$458M
$3K ﹤0.01%
212
– –
VYGR icon
1109
Voyager Therapeutics
VYGR
$187M
$3K ﹤0.01%
178
– –
TVRD
1110
Tvardi Therapeutics
TVRD
$23.5M
$3K ﹤0.01%
5
– –
KDNY
1111
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3K ﹤0.01%
85
– –
FPRX
1112
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3K ﹤0.01%
160
– –
PGNX
1113
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3K ﹤0.01%
388
– –
INSY
1114
DELISTED
Insys Therapeutics, Inc.
INSY
$3K ﹤0.01%
405
– –
ABUS icon
1115
Arbutus Biopharma
ABUS
$865M
$2K ﹤0.01%
304
– –
ASRT
1116
DELISTED
Assertio
ASRT
$2K ﹤0.01%
6
– –
CRBP icon
1117
Corbus Pharmaceuticals
CRBP
$170M
$2K ﹤0.01%
10
– –
CYTK icon
1118
Cytokinetics
CYTK
$11B
$2K ﹤0.01%
298
– –
IMUX icon
1119
Immunic
IMUX
$182M
$2K ﹤0.01%
1
– –
INO icon
1120
Inovio Pharmaceuticals
INO
$79.8M
$2K ﹤0.01%
42
– –
KALA icon
1121
KALA BIO
KALA
$11.8M
– –
0
– –
MCRB icon
1122
Seres Therapeutics
MCRB
$48M
$2K ﹤0.01%
11
– –
MRSN
1123
DELISTED
Mersana Therapeutics
MRSN
$2K ﹤0.01%
5
– –
NERV icon
1124
Minerva Neurosciences
NERV
$188M
$2K ﹤0.01%
27
– –
NVAX icon
1125
Novavax
NVAX
$1.23B
$2K ﹤0.01%
87
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2018 Portfolio in Review

As of Q2 2018, Daiwa Securities Group held 1,215 positions worth $12.7B, up 1.7% from $12.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $755M in Q2 2018, closing 31 positions and reducing 295 holdings. Its most notable exit was Blue Buffalo Pet Products, Inc, an estimated $5.82M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 73% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in VICI Properties worth $115M.

  • Daiwa Securities Group's largest Q2 2018 buy was VICI Properties: 5,575,176 shares worth $115M.
  • Daiwa Securities Group added most to VEREIT, Inc. in Q2 2018, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2018 reduction was Equity Residential, cutting an estimated $189M.
  • Daiwa Securities Group fully exited Blue Buffalo Pet Products, Inc in Q2 2018, selling an estimated $5.82M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $12.7B portfolio in Q2 2018.
  • Daiwa Securities Group opened 45 new positions and closed 31 in Q2 2018.
  • Daiwa Securities Group's portfolio value rose 1.7% quarter-over-quarter to $12.7B.

Based on Daiwa Securities Group's 13F filing for Q2 2018, filed 30 Jul 2018.